Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11 » default

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969


Archive: Volume 11, 2024

Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma

Wang J, Gao W, Yu H, Xu Y, Bai C, Cong Q, Zhu Y

Journal of Hepatocellular Carcinoma 2024, 11:1143-1156

Published Date: 17 June 2024

Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis

Feng Y, Liang L, Jia W, Wang J, Xu C, Zhu D, Xu B, Zhao W, Ling X, Zhou Y, Kong L, Ding W

Journal of Hepatocellular Carcinoma 2024, 11:1095-1112

Published Date: 13 June 2024

LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma

Xiao S, Lu L, Lin Z, Ye X, Su S, Zhang C, You Y, Li W, Huang X, Wu W, Zhou Y

Journal of Hepatocellular Carcinoma 2024, 11:1031-1048

Published Date: 6 June 2024

Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma

Chen BB, Liang PC, Shih TTF, Liu TH, Shen YC, Lu LC, Lin ZZ, Hsu C, Hsu CH, Cheng AL, Shao YY

Journal of Hepatocellular Carcinoma 2024, 11:1015-1029

Published Date: 5 June 2024

A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007–2019

Jean K, Tawheed A, Luong Nguyen LB, Heikal T, Eldaly U, Elhadidy NG, Elghaieb A, Aboudonia A, Tondeur L, Dublineau A, Fontanet A, El-Kassas M

Journal of Hepatocellular Carcinoma 2024, 11:997-1004

Published Date: 31 May 2024

CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma

Palaz F, Ozsoz M, Zarrinpar A, Sahin I

Journal of Hepatocellular Carcinoma 2024, 11:975-995

Published Date: 30 May 2024

A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements

Yalcin S, Lacin S, Kaseb AO, Peynircioğlu B, Cantasdemir M, Çil BE, Hurmuz P, Doğrul AB, Bozkurt MF, Abali H, Akhan O, Şimşek H, Sahin B, Aykan FN, Yücel İ, Tellioğlu G, Selçukbiricik F, Philip PA

Journal of Hepatocellular Carcinoma 2024, 11:953-974

Published Date: 29 May 2024

A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1

He M, Liang C, Pang Y, Jiang M, Long M, Yao Z, Wang X, Zhang R, Wu Q, Liang S, Li J

Journal of Hepatocellular Carcinoma 2024, 11:913-925

Published Date: 22 May 2024

Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1)

Chava S, Ekmen N, Ferraris P, Aydin Y, Moroz K, Wu T, Thung SN, Dash S

Journal of Hepatocellular Carcinoma 2024, 11:839-855

Published Date: 9 May 2024

CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils

Wang P, Xu MH, Xu WX, Dong ZY, Shen YH, Qin WZ

Journal of Hepatocellular Carcinoma 2024, 11:787-800

Published Date: 8 May 2024

A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation

Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z

Journal of Hepatocellular Carcinoma 2024, 11:747-766

Published Date: 23 April 2024

Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors

Gonvers S, Martins-Filho SN, Hirayama A, Calderaro J, Phillips R, Uldry E, Demartines N, Melloul E, Park YN, Paradis V, Thung SN, Alves V, Sempoux C, Labgaa I

Journal of Hepatocellular Carcinoma 2024, 11:707-719

Published Date: 6 April 2024

Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery

Shao G, Ma Y, Qu C, Gao R, Zhu C, Qu L, Liu K, Li N, Sun P, Cao J

Journal of Hepatocellular Carcinoma 2024, 11:679-691

Published Date: 3 April 2024

High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization

Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D

Journal of Hepatocellular Carcinoma 2024, 11:651-663

Published Date: 27 March 2024

The State of Systematic Therapies in Clinic for Hepatobiliary Cancers

Chen W, Hu Z, Li G, Zhang L, Li T

Journal of Hepatocellular Carcinoma 2024, 11:629-649

Published Date: 27 March 2024

Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions

Long X, Zeng H, Zhang Y, Lu Q, Cao Z, Shu H

Journal of Hepatocellular Carcinoma 2024, 11:607-618

Published Date: 23 March 2024

Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis

Nikzad N, Fuentes DT, Roach M, Chowdhury T, Cagley M, Badawy M, Elkhesen A, Hassan M, Elsayes KM, Beretta L, Koay EJ, Jalal PK

Journal of Hepatocellular Carcinoma 2024, 11:595-606

Published Date: 20 March 2024

Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma

Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, Li G

Journal of Hepatocellular Carcinoma 2024, 11:581-594

Published Date: 19 March 2024

Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro

Du YQ, Yuan B, Ye YX, Zhou FL, Liu H, Huang JJ, Wei YF

Journal of Hepatocellular Carcinoma 2024, 11:565-580

Published Date: 19 March 2024

LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma

Wei H, Wu X, Huang L, Long C, Lu Q, Huang Z, Huang Y, Li W, Pu J

Journal of Hepatocellular Carcinoma 2024, 11:543-562

Published Date: 11 March 2024

Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma

Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Zhu X

Journal of Hepatocellular Carcinoma 2024, 11:477-488

Published Date: 4 March 2024

Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy

Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2024, 11:463-475

Published Date: 4 March 2024

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Chamseddine S, LaPelusa M, Xiao L, Mohamed YI, Lee SS, Hu ZI, Hatia RI, Hassan M, Yao JC, Duda DG, Datar S, Amin HM, Kaseb AO

Journal of Hepatocellular Carcinoma 2024, 11:455-461

Published Date: 4 March 2024

Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma

Hall JT, Moon AM, Young M, Tan X, Darawsheh R, Danquah F, Tepper JE, Yanagihara TK

Journal of Hepatocellular Carcinoma 2024, 11:443-454

Published Date: 5 March 2024

Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers

Huang C, Xiao X, Tong L, Gao Z, Ji J, Zhou L, Li Y, Liu L, Feng H, Fang M, Gao C

Journal of Hepatocellular Carcinoma 2024, 11:411-425

Published Date: 27 February 2024

Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment

Liang Y, Zhong D, Yang Q, Tang Y, Qin Y, Su Y, Huang X, Shang J

Journal of Hepatocellular Carcinoma 2024, 11:373-383

Published Date: 22 February 2024

Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia

Alolyan A, Alshammari K, Arabi M, Alshehri A, Alsuhaibani H, Ibnshamsah F, Alsharm A, Mahrous M, Al Zanbagi A, Hassanain M, Bazarbashi S

Journal of Hepatocellular Carcinoma 2024, 11:349-362

Published Date: 16 February 2024

Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Response to Letter]

Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y

Journal of Hepatocellular Carcinoma 2024, 11:347-348

Published Date: 14 February 2024

Lipid Metabolism as a Potential Target of Liver Cancer

Wu K, Lin F

Journal of Hepatocellular Carcinoma 2024, 11:327-346

Published Date: 14 February 2024

The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions

Luo QQ, Li QN, Cai D, Jiang S, Liu SS, Liu MS, Lv C, Wang JK, Zhang KH, Wang T

Journal of Hepatocellular Carcinoma 2024, 11:317-325

Published Date: 8 February 2024

Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy

Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J

Journal of Hepatocellular Carcinoma 2024, 11:305-316

Published Date: 8 February 2024

RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer

Pang JS, Bai XM, Wan WJ, Kang T, Wen R, Li LP, Yin HH, Lu CM, Wen DY, He Y, Yang H

Journal of Hepatocellular Carcinoma 2024, 11:285-304

Published Date: 5 February 2024

Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States

Bteich F, Desai K, Zhang C, Kaur A, Levy RA, Bioh L, Wang A, Sultana S, Kaubisch A, Kinkhabwala M, Bellemare S, Fidvi S, Kanmaniraja D, Berkenblit R, Moon JY, Adedimeji A, Tow CY, Saenger Y

Journal of Hepatocellular Carcinoma 2024, 11:257-269

Published Date: 3 February 2024

Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma

Qiu X, Dong L, Wang K, Zhong X, Xu H, Xu S, Guo H, Wei X, Chen W, Xu X

Journal of Hepatocellular Carcinoma 2024, 11:241-255

Published Date: 2 February 2024

Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular Carcinoma

Zhang C, Tao Y, Yang R, Wang Y, Yu Y, Zhou Y

Journal of Hepatocellular Carcinoma 2024, 11:229-240

Published Date: 26 January 2024

A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy

Yang H, Lu L, Guo W, Gong B, Wang X, Chen Y, Chen X

Journal of Hepatocellular Carcinoma 2024, 11:219-228

Published Date: 25 January 2024

A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study

Wang H, Chen JJ, Yin SY, Sheng X, Wang HX, Lau WY, Dong H, Cong WM

Journal of Hepatocellular Carcinoma 2024, 11:191-206

Published Date: 24 January 2024

Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease

Miao T, Lou X, Dong S, Zhang X, Guan W, Zhang Y, Li L, Yuan X, Ma D, Nan Y

Journal of Hepatocellular Carcinoma 2024, 11:145-157

Published Date: 18 January 2024

Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma

Wang Z, Kong L, Zhang R, Yang X, Cao Z, Xu T, Zhang H, Dou Y

Journal of Hepatocellular Carcinoma 2024, 11:131-143

Published Date: 16 January 2024

The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein Levels

Cong T, Yang C, Cao Q, Ren J, Luo Y, Yuan P, Zheng B, Liu Y, Yang H, Kang W, Ou A, Li X

Journal of Hepatocellular Carcinoma 2024, 11:95-111

Published Date: 17 January 2024

First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison

Mahn R, Glüer OA, Sadeghlar F, Möhring C, Zhou T, Anhalt T, Monin MB, Kania A, Glowka TR, Feldmann G, Brossart P, Kalff JC, Schmidt-Wolf IGH, Strassburg CP, Gonzalez-Carmona MA

Journal of Hepatocellular Carcinoma 2024, 11:81-94

Published Date: 13 January 2024

A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy

Han R, Gan L, Lang M, Li G, Chen L, Tian X, Zhu K, Sun L, Song T

Journal of Hepatocellular Carcinoma 2024, 11:51-64

Published Date: 12 January 2024

PD1 and TIM3 Expression is Associated with Very Early Hepatocellular Carcinoma Recurrence After Percutaneous Thermal Ablation

Ghelfi J, Macek Jilkova Z, Sengel C, Brusset B, Teyssier Y, Costentin C, Mercey-Ressejac M, Dumolard L, Manceau M, Mathieu E, Bricault I, Decaens T

Journal of Hepatocellular Carcinoma 2024, 11:39-50

Published Date: 9 January 2024

PRMT1 Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular Carcinoma

Yan J, Li KX, Yu L, Yuan HY, Zhao ZM, Lin J, Wang CS

Journal of Hepatocellular Carcinoma 2024, 11:15-27

Published Date: 6 January 2024

An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma

Yang H, Lei G, Deng Z, Sun F, Tian Y, Cheng J, Yu H, Li C, Bai C, Zhang S, An G, Yang P

Journal of Hepatocellular Carcinoma 2024, 11:1-13

Published Date: 9 January 2024